The Motley Fool··Jonathan PoncianoB Group Doubles Down on Biotech Amid 58% Decline; ADMA Shows Profitability Gains
B Group increases ADMA stake to 21.4% of AUM amid 58% stock decline, betting on 22% profit growth and 28% ASCENIV sales momentum.
ADMAbiotechfund investment